Recursion Pharmaceuticals is trading at $3.36, up 5.07%, with no clear company-specific catalyst identified for the intraday gain.
- Recent coverage references a September 11 insider sale and earlier second-quarter results.
- The next listed investor event is September 15; neither directly explains the September 14 move.
- Broader markets are modestly lower, so the gain does not clearly track overall market sentiment.